Leukemia & Lymphoma, 54, 4, pp. 874-7 Abouyahya, I, Alhan, C, Westers, T M, te Boekhorst, P A, Kappers-Klunne, MC, Coenen, J L, Heyning, F H, Huls, G A, de Wolf, JT, Imholz, A L, Koene, H R, Veth, G, de Kruijf, E J F M, Muus, P, Planken, E V, Segeren, C M, Vasmel, W L, van der Velden, A M, Velders, G A, Koedam, J, Ossenkoppele, G J & van de Loosdrecht, A A 2013, ' Treatment with lenalidomide in myelodysplastic syndromes with deletion 5q: results from the Dutch named patient program ', Leukemia and Lymphoma, vol. 54, no. 4, pp. 874-877 . https://doi.org/10.3109/10428194.2012.728702 Leukemia and Lymphoma, 54(4), 874-877. Informa Healthcare Leukemia & Lymphoma, 54, 874-7 Leukemia and Lymphoma, 54(4), 874-877. TAYLOR & FRANCIS LTD Leukemia & Lymphoma, 54(4), 874-877
Meerveld-Eggink, A, van der Velden, A M T, Ossenkoppele, G J, van de Loosdrecht, A A, Biesma, D H & Rijkers, G T 2009, ' Antibody Response to Polysaccharide Conjugate Vaccines after Nonmyeloablative Allogeneic Stem Cell Transplantation ', Biology of Blood and Marrow Transplantation, vol. 15, no. 12, pp. 1523-1530 . https://doi.org/10.1016/j.bbmt.2009.07.020 Biology of Blood and Marrow Transplantation, 15(12), 1523-1530. Elsevier Inc. Biology of Blood and Marrow Transplantation, 15(12), 1523-1530. ELSEVIER SCIENCE INC